Farydak
Product Images NDC 73116-101

This is a description of medication named Farydak, which comes in the form of capsules. It contains panobinostat lactate and is used for oral consumption only. The product comes in a blister pack with 6 capsules and a Medication Guide. The capsules contain 10mg of panobinostat and should not be opened, crushed, or chewed; they should be swallowed whole with water. Farydak should be stored at 20°C to 25°C, and must be kept out of the reach of children. There is additional information about the manufacturer, Novartis Farmaceutica SA, and the distributor, Secura Bio, Inc, and a website to find more information regarding the product.*

This is a medication called FARYDAK (panobinostat) that comes in blister packs of 6 capsules, each capsule containing 15mg of panobinostat. The NDC code is 73116-101-06 and the total weight of the 6 capsules is 1886 mg. The medication is taken orally by swallowing the capsule whole with water, and the blister pack should be stored in the original carton to protect it from light. The medication guide is enclosed and should be dispensed with the medication. Dosage and administration information is available in the package insert. The medication should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C and 30°C (59°F and 86°F). For more information, visit www.FARYDAK.com or call 1-844-9-SECURA (1-844-973-2872). This medication is distributed by Secura Bio, Inc.*

This is a chart showing the probability of progression-free survival over time for two groups of patients, one group receiving FARYDAK+BTZ+Dex (N=57/94) and the other group receiving placebo+BTZ+Dex (VN=72/99), where BTZ stands for bortezomib and Dex stands for dexamethasone. The chart indicates the censoring times and the number of patients at risk over time.*